Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if HUMA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
17 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bullish
Last trade: buy 29 days ago
Red flags: 0
164 filers reported a long position in HUMA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| ANTIPODES PARTNERS Ltd | $7.9M | 10.1M | +76.5% |
| VANGUARD CAPITAL MANAGEMENT LLC | $7.9M | 10.1M | +41.2% |
| Alyeska Investment Group, L.P. | $4.7M | 6M | New |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | $3.9M | 5M | New |
| BlackRock, Inc. | $3.8M | 4.8M | -60.7% |
| GREAT POINT PARTNERS LLC | $2.9M | 3.8M | Unchanged |
| UBS Group AG | $2.2M | 2.8M | +2.2% |
| AQR CAPITAL MANAGEMENT LLC | $2M | 2.6M | +34.9% |
| GEODE CAPITAL MANAGEMENT, LLC | $1.7M | 2.2M | -40.3% |
| MILLENNIUM MANAGEMENT LLC | $1.5M | 1.9M | +1,665.1% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.